At close: November 27 at 7:31 PM GMT+1
Loading Chart for R9U2.BE
DELL
- Previous Close
8.64 - Open
0.00 - Bid 8.78 x --
- Ask 9.10 x --
- Day's Range
0.00 - 0.00 - 52 Week Range
0.00 - 14.25 - Volume
0 - Avg. Volume
1 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Feb 26, 2025 - Mar 3, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: R9U2.BE
View MorePerformance Overview: R9U2.BE
Trailing total returns as of 11/27/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
R9U2.BE
13.40%
S&P/TSX Composite index
21.61%
1-Year Return
R9U2.BE
3.83%
S&P/TSX Composite index
26.79%
3-Year Return
R9U2.BE
56.19%
S&P/TSX Composite index
20.65%
5-Year Return
R9U2.BE
8.78%
S&P/TSX Composite index
49.62%
Compare To: R9U2.BE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
8.92
+3.24%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.1120
+8.53%
Mkt Cap EUR 56.21M
Industry Drug Manufacturers—Specialty & Generic
5.70
+2.89%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.0210
-9.48%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.1500
+1.01%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.1119
+8.43%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.0969
-9.86%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.3720
+5.68%
Mkt Cap EUR 134.143M
Industry Drug Manufacturers—Specialty & Generic
4.2320
0.00%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
3.6600
-2.40%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
Statistics: R9U2.BE
View MoreValuation Measures
As of 11/26/2024
Market Cap
2.08B
Enterprise Value
2.42B
Trailing P/E
33.42
Forward P/E
17.15
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.93
Price/Book (mrq)
1.20
Enterprise Value/Revenue
2.26
Enterprise Value/EBITDA
6.73
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--